Key factors that impact long-term weight loss in patients prescribed GLP-1 RA medications

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or obesity. The study was published in JAMA Network Open.

Click here to view the original article.